The CD1d-binding glycolipid α-galactosylceramide enhances humoral immunity to T-dependent and T-independent antigen in a CD1d-dependent manner

Immunology

Volumn 119, Issue 1, 2006, Pages 116-125

  Lang, Gillian A ^a   Exley, Mark A ^b   Lang, Mark L ^a,c  

^a DARTMOUTH MEDICAL SCHOOL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c NONE   (United States)

Author keywords

Antibodies; B cells; CD1d; Natural killer T cells

Indexed keywords

ALPHA GALACTOSYLCERAMIDE; CD1D ANTIGEN; GLYCOLIPID; IMMUNOGLOBULIN G2B; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; VACCINE;

ANIMAL CELL; ANIMAL TISSUE; ANTIBODY PRODUCTION; ANTIBODY RESPONSE; ANTIGEN ANTIBODY REACTION; ANTIGEN BINDING; ARTICLE; B LYMPHOCYTE; CONTROLLED STUDY; FEMALE; HUMORAL IMMUNITY; HYPOTHESIS; IMMUNOGLOBULIN PRODUCTION; MALE; MOUSE; NATURAL KILLER T CELL; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; ANTIBODY FORMATION; ANTIGENS, CD1; CYTOTOXICITY, IMMUNOLOGIC; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; GALACTOSYLCERAMIDES; HISTOCOMPATIBILITY ANTIGENS CLASS II; IMMUNIZATION; IMMUNOGLOBULIN G; KILLER CELLS, NATURAL; MALE; MICE; MICE, INBRED C57BL; OVALBUMIN; RECEPTORS, ANTIGEN, T-CELL, ALPHA-BETA; STAINING AND LABELING; T-LYMPHOCYTES, HELPER-INDUCER;

EID: 33746927114     PISSN: 00192805     EISSN: 13652567     Source Type: Journal    
DOI: 10.1111/j.1365-2567.2006.02413.x     Document Type: Article

References (40)

1. Jung S, Unutmaz D, Wong P et al. In vivo depletion of CD11c(+) dendritic cells abrogates priming of CD8(+) T cells by exogenous cell-associated antigens. Immunity 2002; 17:211-20.
2. McHeyzer-Williams LJ, McHeyzer-Williams MG. Antigen-specific memory B cell development. Annu Rev Immunol 2005; 23:487-513.
3. Slifka MK, Antia R, Whitmire JK, Ahmed R. Humoral immunity due to long-lived plasma cells. Immunity 1998; 8:363-72.
4. Lanzavecchia A. Receptor-mediated antigen uptake and its effect on antigen presentation to class II-restricted T lymphocytes. Annu Rev Immunol 1990; 8:773-93.
5. Madsen L, Labrecque N, Engberg J et al. Mice lacking all conventional MHC class II genes. Proc Natl Acad Sci USA 1999; 96:10338-43.
6. Calderhead DM, Kosaka Y, Manning EM, Noelle RJ. CD40-CD154 interactions in B-cell signaling. Curr Top Microbiol Immunol 2000; 245:73-99.
7. Porcelli SA, Modlin RL. The CD1 system. Antigen-presenting molecules for T cell recognition of lipids and glycolipids. Annu Rev Immunol 1999; 17:297-329.
8. Godfrey DI, MacDonald HR, Kronenberg M, Smyth MJ, Van Kaer L. NKT cells: what's in a name? Nat Rev Immunol 2004; 4:231-7.
9. Gumperz JE. Antigen specificity of semi-invariant CD1d-restricted T cell receptors: the best of both worlds? Immunol Cell Biol 2004; 82:285-94.
10. Godfrey DI, Hammond KJ, Poulton LD, Smyth MJ, Baxter AG. NK T cells. Facts, functions and fallacies. Immunol Today 2000; 21:573-83.
11. Singh N, Hong S, Scherer DC et al. Cutting edge: activation of NK T cells by CD1d and alpha-galactosylceramide directs conventional T cells to the acquisition of a Th2 phenotype. J Immunol 1999; 163:2373-7.
12. Burdin N, Brossay L, Kronenberg M. Immunization with alpha- galactosylceramide polarizes CD1-reactive NK T cells towards Th2 cytokine synthesis. Eur J Immunol 1999; 29:2014-25.
13. Cui J, Watanabe N, Kawano T et al. Inhibition of T helper cell type 2 cell differentiation and immunoglobulin E response by ligand-activated Vα14 natural killer T cells. J Exp Med 1999; 190:783-92.
14. Fujii S, Shimizu K, Kronenberg M, Steinman RM. Prolonged IFN-gamma-producing NKT response induced with alphagalactosylceramide-loaded DCs. Nat Immunol 2002; 3:867-74.
15. Campos RA, Szczepanik M, Itakura A et al. Cutaneous immunization rapidly activates liver invariant Vα14 NKT cells stimulating B-1 B cells to initiate T cell recruitment for elicitation of contact sensitivity. J Exp Med 2003; 198:1785-96.
16. Galli G, Nuti S, Tavarini S et al. CD1d-restricted help to B cells by human invariant natural killer T lymphocytes. J Exp Med 2003; 197:1051-7.
17. Kitamura H, Ohta A, Sekimoto M et al. α-galactosylceramide induces early B-cell activation through IL-4 production by NKT cells. Cell Immunol 2000; 199:37-42.
18. Procopio DO, Almeida IC, Torrecilhas AC et al. Glycosylphosphatidylinositol-anchored mucin-like glycoproteins from Trypanosoma cruzi bind to CD1d but do not elicit dominant innate or adaptive immune responses via the CD1d/NKT cell pathway. J Immunol 2002; 169:3926-33.
19. Schofield L, McConville MJ, Hansen D et al. CD1d-restricted immunoglobulin G formation to GPI-anchored antigens mediated by NKT cells. Science 1999; 283:225-9.
20. Yoshimoto T, Min B, Sugimoto T et al. Non-redundant roles for CD1d-restricted natural killer T cells and conventional CD4+ T cells in the induction of immunoglobulin E antibodies in response to interleukin 18 treatment of mice. J Exp Med 2003; 197:997-1005.
21. Lisbonne M, Diem S, de Castro Keller A et al. Cutting edge: invariant V alpha 14 NKT cells are required for allergen-induced airway inflammation and hyper-reactivity in an experimental asthma model. J Immunol 2003; 171:1637-41.
22. Molano A, Park SH, Chiu YH, Nosseir S, Bendelac A, Tsuji M. Cutting edge. The IgG response to the circumsporozoite protein is MHC class II-dependent and CD1d-independent: exploring the role of GPIs in NK T cell activation and anti-malarial responses. J Immunol 2000; 164:5005-9.
23. Belperron AA, Dailey CM, Bockenstedt LK. Infection-induced marginal zone B cell production of Borrelia hermsii-specific antibody is impaired in the absence of CD1d. J Immunol 2005; 174:5681-6.
24. Kumar H, Belperron A, Barthold SW, Bockenstedt LK. Cutting edge: CD1d deficiency impairs murine host defense against the spirochete, Borrelia burgdorferi. J Immunol 2000; 165:4797-801.
25. Kobrynski LJ, Sousa AO, Nahmias AJ, Lee FK. Cutting edge. antibody production to pneumococcal polysaccharides requires CD1 molecules and CD8+ T cells. J Immunol 2005; 174:1787-90.
26. Ko SY, Ko HJ, Chang WS, Park SH, Kweon MN, Kang CY. α- galactosylceramide can act as a nasal vaccine adjuvant inducing protective immune responses against viral infection and tumor. J Immunol 2005; 175:3309-17.
27. Lang GA, Maltsev SD, Besra GS, Lang ML. Presentation of alpha-galactosylceramide by murine CD1d to natural killer T cells is facilitated by plasma membrane glycolipid rafts. Immunology 2004; 112:386-96.
28. Lang GA, Illarionov PA, Glatman-Freedman A, Besra GS, Lang ML. BCR targeting of biotin-α-galactosylceramide leads to enhanced presentation on CD1d and requires transport of BCR to CD1d-containing endocytic compartments. Int Immunol 2005; 17:899-908.
29. Exley MA, Bigley NJ, Cheng O et al. Innate immune response to encephalomyocarditis virus infection mediated by CD1d. Immunology 2003; 110:519-26.
30. Hermans IF, Silk JD, Gileadi U et al. NKT cells enhance CD4+ and CD8+ T cell responses to soluble antigen in vivo through direct interaction with dendritic cells. J Immunol 2003; 171:5140-7.
31. Mehta PK, Khuller GK. Protective immunity to experimental tuberculosis by mannophosphoinositides of mycobacteria. Med Microbiol Immunol (Berl) 1988; 177:265-84.
32. Hamasur B, Haile M, Pawlowski A, Schroder U, Kallenius G, Svenson SB. A mycobacterial lipoarabinomannan specific monoclonal antibody and its F(ab′) fragment prolong survival of mice infected with Mycobacterium tuberculosis. Clin Exp Immunol 2004; 138:30-8.
33. Lang ML, Glatman-Freedman A. Do CD1-restricted T cells contribute to antibody-mediated immunity against Mycobacterium tuberculosis? Infect Immun 2006; 74:803-9.
34. + T cells. Eur J Immunol 1998; 28:3172-82.
35. McIntyre TM, Klinman DR, Rothman P et al. Transforming growth factor beta 1 selectivity stimulates immunoglobulin G2b secretion by lipopolysaccharide- activated murine B cells. J Exp Med 1993; 177:1031-7.
36. Park SR, Seo GY, Choi AJ, Stavnezer J, Kim PH. Analysis of transforming growth factor-beta1-induced Ig germ-line gamma2b transcription and its implication for IgA isotype switching. Eur J Immunol 2005; 35:946-56.
37. Snapper CM, Finkelman FD, Paul WE. Regulation of IgG1 and IgE production by interleukin 4. Immunol Rev 1988; 102:51-75.
38. Taniguchi M, Harada M, Kojo S, Nakayama T, Wakao H. The regulatory role of Vα14 NKT cells in innate and acquired immune response. Annu Rev Immunol 2003; 21:483-513.
39. Finkelman FD, Katona IM, Mosmann TR, Coffman RL. IFN-γ regulates the isotypes of Ig secreted during in vivo humoral immune responses. J Immunol 1988; 140:1022-7.
40. Fujii S, Shimizu K, Smith C, Bonifaz L, Steinman RM. Activation of natural killer T cells by α-galactosylceramide rapidly induces the full maturation of dendritic cells in vivo and thereby acts as an adjuvant for combined CD4 and CD8 T cell immunity to a coadministered protein. J Exp Med 2003; 198: 267-79.